Event 18 Mar 2020 Dispute Avoidance and Resolution 20th Anniversary ITR Global Transfer Pricing Forum 2020
Event 03 Mar 2020 Transfer Pricing Concerns International Tax Review's 3rd Annual Leading Women In Tax Forum
Story 13 Feb 2020 "We have to tell a different story" Provoking thoughtful discussions for US Black History Month
Alert 12 Feb 2020 FTC and FDA Announce Plans to Combat Anticompetitive Practices in the "Biologic Marketplace"
Alert 11 Feb 2020 BMWi plans further tightening of investment control in M&A transactions of foreign investors
Alert 11 Feb 2020 CAA v R (on the application of Jet2.com Limited): the Court of Appeal confirms the dominant purpose test for legal advice privilege
Alert 11 Feb 2020 New CFIUS FIRRMA Tool Helps Users Determine Jurisdiction Under Overhauled CFIUS Rules
Alert 11 Feb 2020 SL Claimants v Tesco: High Court clarifies the confidentiality of documents referred to in separate criminal proceedings
Alert 10 Feb 2020 RBI v Asia Coal Energy: Court of Appeal confirms that communication of solicitor instructions does not of itself waive underlying privilege
Alert 07 Feb 2020 US Department of Commerce Publishes Final Rule on Treatment of Alleged "Currency Undervaluation" in Countervailing Duty Proceedings
Alert 07 Feb 2020 Bureau of Industry and Security Issues First "Emerging Technology" Control on Artificial Intelligence-Based Geospatial Imagery Software
Article 05 Feb 2020 Newman/Martoma: The Insider Trading Law’s Impasse and the Promise of Congressional Action
Alert 04 Feb 2020 New SEC C&DIs Clarify Aspects of Omitting Discussion of Third Year of Financials from the MD&A
Alert 03 Feb 2020 Amendments to the JFTC Merger Guidelines and Policies in accordance with Digital Economy
Alert 30 Jan 2020 The end of the e-book's secondhand market - Court of Justice of the European Union forbids resale without rights holders' consent
Insight 30 Jan 2020 Biotech boosts US healthcare M&A in 2019 The healthcare sector (incorporating pharma, medical and biotech) has seen M&A valued at US$256.5 billion across 645 deals in 2019. This is a decrease of 9 percent by volume, but an increase of 121 percent by value.
Insight 30 Jan 2020 Consumer deals fall but disruption may be a driver Restructurings and uncertainty are hitting the US consumer sector. Retail M&A deal volume dropped 11 percent year-on-year to 459 deals, while deal value dropped 36 percent to US$76.87 billion.
Insight 30 Jan 2020 SaaS, cashless and convergence drive tech to the top Technology continued to be among the most active subsectors for US M&A in 2019, with 1,138 deals announced worth a total of US$206 billion. This represents a marginal decrease of 3 percent in volume and 7 percent in value compared to 2018 activity.
Insight 30 Jan 2020 Key dealmaking decisions from Delaware and New York We focus on two H2 2019 rulings that could affect M&A transactions in the future
Insight 30 Jan 2020 Sustainability is an increasing focus for global M&A Dealmakers are placing more emphasis on sustainability in the context of their investment practices. This is occurring despite a lack of US federal regulation on companies' sustainability reporting.
Insight 30 Jan 2020 Private equity stands its ground in 2019 In line with the wider US M&A markets, PE deals held firm through 2019 with 1,329 buyouts, worth US$208 billion, representing a decline of 9 percent by volume, but just a 4 percent fall by value relative to 2018.
Insight 30 Jan 2020 Real estate deals build on very solid foundations The trend for megadeals in US real estate continued in 2019, with 38 transactions in the sector, worth a total US$56.6 billion—but overall deal volume was down 17 percent and deal value fell 25 percent year-on-year
Insight 30 Jan 2020 Pricing and pull backs affect oil & gas M&A in 2019 M&A in the US oil & gas sector slowed in 2019, with 190 deals worth US$158 billion, down 38 percent in volume and 45 percent in value, mirroring steep declines in global M&A in the industry.
Insight 30 Jan 2020 Ahead of the pack: US M&A 2019 While global M&A fell in 2019, the US forged ahead, maintaining its year-on-year value and taking a greater share of the global deal market.
Insight 30 Jan 2020 US dealmakers steer a steady path through global headwinds As the rest of the world backed away from the deal table, confident US corporates continued buying businesses—especially in the life sciences and TMT sectors, and particularly in the domestic market.
Alert 29 Jan 2020 Helping China-owned companies in Vietnam in the era of rising tariffs, changing rules, and increased enforcement
